Global Biodefense Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	166 Pages	TechNavio	June, 2024	INF19033441

Best Price Guarantee
Price	from $2,500
Length	166 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19033441

Global Biodefense Market 2024-2028

The biodefense market is forecasted to grow by USD -7161.34 million during 2023-2028, accelerating at a CAGR of -4.96% during the forecast period. The report on the biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing threat posed by biological agents, rising threat of bioterrorism, and growing public awareness of impact of infectious diseases.

Technavio's biodefense market is segmented as below:

By Type

Vaccines
Drugs

By Application

COVID 19
Anthrax
Smallpox
Botulism
Others

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the rising product launches and strategic alliances among market participants as one of the prime reasons driving the biodefense market growth during the next few years. Also, favorable government initiatives and globalization and increased travel requiring better immuity will lead to sizable demand in the market.

The report on the biodefense market covers the following areas:

Biodefense market sizing
Biodefense market forecast
Biodefense market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alnylam Pharmaceuticals Inc., Appili Therapeutics Inc., AstraZeneca PLC, Bavarian Nordic AS, Chimerix Inc., Dynavax Technologies Corp., Elusys Therapeutics Inc., Emergent BioSolutions Inc., GlaxoSmithKline PLC, Merck and Co. Inc., Neogen Corp., Novavax Inc., Porton Biopharma Ltd., Sanofi SA, Serum Institute of India Pvt. Ltd., SIGA Technologies Inc., Soligenix Inc., Tonix Pharmaceuticals Holding Corp., Zoetis Inc., and Johnson and Johnson. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary €“ Chart on Market Overview; Exhibit 02: Executive Summary €“ Data Table on Market Overview; Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics; Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type; Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Application; Exhibit 07: Executive Summary €“ Chart on Incremental Growth; Exhibit 08: Executive Summary €“ Data Table on Incremental Growth; Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global biodefense market 2018 - 2022; Exhibit 18: Historic Market Size €“ Data Table on global biodefense market 2018 - 2022 ($ million); 4.2 Type Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size €“ Type Segment 2018 - 2022 ($ million); 4.3 Application Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size €“ Application Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size €“ Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size €“ Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants €“ Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes €“ Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry €“ Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 30: Chart on Type - Market share 2023-2028 (%); Exhibit 31: Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Exhibit 32: Chart on Comparison by Type; Exhibit 33: Data Table on Comparison by Type; 6.3 Vaccines - Market size and forecast 2023-2028; Exhibit 34: Chart on Vaccines - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Vaccines - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Vaccines - Year-over-year growth 2023-2028 (%); 6.4 Drugs - Market size and forecast 2023-2028; Exhibit 38: Chart on Drugs - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Drugs - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Drugs - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Drugs - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Type; Exhibit 42: Market opportunity by Type ($ million); Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Exhibit 44: Chart on Application - Market share 2023-2028 (%); Exhibit 45: Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Exhibit 46: Chart on Comparison by Application; Exhibit 47: Data Table on Comparison by Application; 7.3 COVID 19 - Market size and forecast 2023-2028; Exhibit 48: Chart on COVID 19 - Market size and forecast 2023-2028 ($ million); Exhibit 49: Data Table on COVID 19 - Market size and forecast 2023-2028 ($ million); Exhibit 50: Chart on COVID 19 - Year-over-year growth 2023-2028 (%); Exhibit 51: Data Table on COVID 19 - Year-over-year growth 2023-2028 (%); 7.4 Anthrax - Market size and forecast 2023-2028; Exhibit 52: Chart on Anthrax - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Anthrax - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Anthrax - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Anthrax - Year-over-year growth 2023-2028 (%); 7.5 Smallpox - Market size and forecast 2023-2028; Exhibit 56: Chart on Smallpox - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Smallpox - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Smallpox - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Smallpox - Year-over-year growth 2023-2028 (%); 7.6 Botulism - Market size and forecast 2023-2028; Exhibit 60: Chart on Botulism - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Botulism - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Botulism - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Botulism - Year-over-year growth 2023-2028 (%); 7.7 Others - Market size and forecast 2023-2028; Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Application; Exhibit 68: Market opportunity by Application ($ million); Exhibit 69: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 73: Chart on Geographic comparison; Exhibit 74: Data Table on Geographic comparison; 9.3 Asia - Market size and forecast 2023-2028; Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.4 North America - Market size and forecast 2023-2028; Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.5 Europe - Market size and forecast 2023-2028; Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 India - Market size and forecast 2023-2028; Exhibit 99: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on India - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on India - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 Germany - Market size and forecast 2023-2028; Exhibit 107: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 108: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 109: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 110: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 111: Market opportunity By Geographical Landscape ($ million); Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 113: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 114: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 115: Overview on factors of disruption; 11.4 Industry risks; Exhibit 116: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 117: Vendors covered; 12.2 Market positioning of vendors; Exhibit 118: Matrix on vendor position and classification; 12.3 Alnylam Pharmaceuticals Inc.; Exhibit 119: Alnylam Pharmaceuticals Inc. - Overview; Exhibit 120: Alnylam Pharmaceuticals Inc. - Product / Service; Exhibit 121: Alnylam Pharmaceuticals Inc. - Key offerings; 12.4 Appili Therapeutics Inc.; Exhibit 122: Appili Therapeutics Inc. - Overview; Exhibit 123: Appili Therapeutics Inc. - Product / Service; Exhibit 124: Appili Therapeutics Inc. - Key offerings; 12.5 AstraZeneca PLC; Exhibit 125: AstraZeneca PLC - Overview; Exhibit 126: AstraZeneca PLC - Product / Service; Exhibit 127: AstraZeneca PLC - Key news; Exhibit 128: AstraZeneca PLC - Key offerings; 12.6 Bavarian Nordic AS; Exhibit 129: Bavarian Nordic AS - Overview; Exhibit 130: Bavarian Nordic AS - Product / Service; Exhibit 131: Bavarian Nordic AS - Key offerings; 12.7 Chimerix Inc.; Exhibit 132: Chimerix Inc. - Overview; Exhibit 133: Chimerix Inc. - Product / Service; Exhibit 134: Chimerix Inc. - Key offerings; 12.8 Dynavax Technologies Corp.; Exhibit 135: Dynavax Technologies Corp. - Overview; Exhibit 136: Dynavax Technologies Corp. - Product / Service; Exhibit 137: Dynavax Technologies Corp. - Key offerings; 12.9 Elusys Therapeutics Inc.; Exhibit 138: Elusys Therapeutics Inc. - Overview; Exhibit 139: Elusys Therapeutics Inc. - Product / Service; Exhibit 140: Elusys Therapeutics Inc. - Key offerings; 12.10 Emergent BioSolutions Inc.; Exhibit 141: Emergent BioSolutions Inc. - Overview; Exhibit 142: Emergent BioSolutions Inc. - Product / Service; Exhibit 143: Emergent BioSolutions Inc. - Key news; Exhibit 144: Emergent BioSolutions Inc. - Key offerings; 12.11 GlaxoSmithKline Plc; Exhibit 145: GlaxoSmithKline Plc - Overview; Exhibit 146: GlaxoSmithKline Plc - Business segments; Exhibit 147: GlaxoSmithKline Plc - Key news; Exhibit 148: GlaxoSmithKline Plc - Key offerings; Exhibit 149: GlaxoSmithKline Plc - Segment focus; 12.12 Johnson and Johnson; Exhibit 150: Johnson and Johnson - Overview; Exhibit 151: Johnson and Johnson - Business segments; Exhibit 152: Johnson and Johnson - Key news; Exhibit 153: Johnson and Johnson - Key offerings; Exhibit 154: Johnson and Johnson - Segment focus; 12.13 Novavax Inc.; Exhibit 155: Novavax Inc. - Overview; Exhibit 156: Novavax Inc. - Product / Service; Exhibit 157: Novavax Inc. - Key offerings; 12.14 Sanofi SA; Exhibit 158: Sanofi SA - Overview; Exhibit 159: Sanofi SA - Business segments; Exhibit 160: Sanofi SA - Key news; Exhibit 161: Sanofi SA - Key offerings; Exhibit 162: Sanofi SA - Segment focus; 12.15 SIGA Technologies Inc.; Exhibit 163: SIGA Technologies Inc. - Overview; Exhibit 164: SIGA Technologies Inc. - Product / Service; Exhibit 165: SIGA Technologies Inc. - Key offerings; 12.16 Soligenix Inc.; Exhibit 166: Soligenix Inc. - Overview; Exhibit 167: Soligenix Inc. - Business segments; Exhibit 168: Soligenix Inc. - Key offerings; Exhibit 169: Soligenix Inc. - Segment focus; 12.17 Tonix Pharmaceuticals Holding Corp.; Exhibit 170: Tonix Pharmaceuticals Holding Corp. - Overview; Exhibit 171: Tonix Pharmaceuticals Holding Corp. - Product / Service; Exhibit 172: Tonix Pharmaceuticals Holding Corp. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 173: Inclusions checklist; Exhibit 174: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 175: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 176: Research methodology; Exhibit 177: Validation techniques employed for market sizing; Exhibit 178: Information sources; 13.5 List of abbreviations; Exhibit 179: List of abbreviations
Exhibits:: Exhibits1: Executive Summary €“ Chart on Market Overview; Exhibits2: Executive Summary €“ Data Table on Market Overview; Exhibits3: Executive Summary €“ Chart on Global Market Characteristics; Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type; Exhibits6: Executive Summary €“ Chart on Market Segmentation by Application; Exhibits7: Executive Summary €“ Chart on Incremental Growth; Exhibits8: Executive Summary €“ Data Table on Incremental Growth; Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size €“ Data Table on global biodefense market 2018 - 2022 ($ million); Exhibits19: Historic Market Size €“ Type Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size €“ Application Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size €“ Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size €“ Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants €“ Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes €“ Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry €“ Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Type - Market share 2023-2028 (%); Exhibits31: Data Table on Type - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Type; Exhibits33: Data Table on Comparison by Type; Exhibits34: Chart on Vaccines - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Vaccines - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Vaccines - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Drugs - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Drugs - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Drugs - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Drugs - Year-over-year growth 2023-2028 (%); Exhibits42: Market opportunity by Type ($ million); Exhibits43: Data Table on Market opportunity by Type ($ million); Exhibits44: Chart on Application - Market share 2023-2028 (%); Exhibits45: Data Table on Application - Market share 2023-2028 (%); Exhibits46: Chart on Comparison by Application; Exhibits47: Data Table on Comparison by Application; Exhibits48: Chart on COVID 19 - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on COVID 19 - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on COVID 19 - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on COVID 19 - Year-over-year growth 2023-2028 (%); Exhibits52: Chart on Anthrax - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Anthrax - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Anthrax - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Anthrax - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Smallpox - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Smallpox - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Smallpox - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Smallpox - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Botulism - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Botulism - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Botulism - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Botulism - Year-over-year growth 2023-2028 (%); Exhibits64: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits65: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits66: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits67: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits68: Market opportunity by Application ($ million); Exhibits69: Data Table on Market opportunity by Application ($ million); Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits73: Chart on Geographic comparison; Exhibits74: Data Table on Geographic comparison; Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits111: Market opportunity By Geographical Landscape ($ million); Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits113: Impact of drivers and challenges in 2023 and 2028; Exhibits114: Overview on Criticality of inputs and Factors of differentiation; Exhibits115: Overview on factors of disruption; Exhibits116: Impact of key risks on business; Exhibits117: Vendors covered; Exhibits118: Matrix on vendor position and classification; Exhibits119: Alnylam Pharmaceuticals Inc. - Overview; Exhibits120: Alnylam Pharmaceuticals Inc. - Product / Service; Exhibits121: Alnylam Pharmaceuticals Inc. - Key offerings; Exhibits122: Appili Therapeutics Inc. - Overview; Exhibits123: Appili Therapeutics Inc. - Product / Service; Exhibits124: Appili Therapeutics Inc. - Key offerings; Exhibits125: AstraZeneca PLC - Overview; Exhibits126: AstraZeneca PLC - Product / Service; Exhibits127: AstraZeneca PLC - Key news; Exhibits128: AstraZeneca PLC - Key offerings; Exhibits129: Bavarian Nordic AS - Overview; Exhibits130: Bavarian Nordic AS - Product / Service; Exhibits131: Bavarian Nordic AS - Key offerings; Exhibits132: Chimerix Inc. - Overview; Exhibits133: Chimerix Inc. - Product / Service; Exhibits134: Chimerix Inc. - Key offerings; Exhibits135: Dynavax Technologies Corp. - Overview; Exhibits136: Dynavax Technologies Corp. - Product / Service; Exhibits137: Dynavax Technologies Corp. - Key offerings; Exhibits138: Elusys Therapeutics Inc. - Overview; Exhibits139: Elusys Therapeutics Inc. - Product / Service; Exhibits140: Elusys Therapeutics Inc. - Key offerings; Exhibits141: Emergent BioSolutions Inc. - Overview; Exhibits142: Emergent BioSolutions Inc. - Product / Service; Exhibits143: Emergent BioSolutions Inc. - Key news; Exhibits144: Emergent BioSolutions Inc. - Key offerings; Exhibits145: GlaxoSmithKline Plc - Overview; Exhibits146: GlaxoSmithKline Plc - Business segments; Exhibits147: GlaxoSmithKline Plc - Key news; Exhibits148: GlaxoSmithKline Plc - Key offerings; Exhibits149: GlaxoSmithKline Plc - Segment focus; Exhibits150: Johnson and Johnson - Overview; Exhibits151: Johnson and Johnson - Business segments; Exhibits152: Johnson and Johnson - Key news; Exhibits153: Johnson and Johnson - Key offerings; Exhibits154: Johnson and Johnson - Segment focus; Exhibits155: Novavax Inc. - Overview; Exhibits156: Novavax Inc. - Product / Service; Exhibits157: Novavax Inc. - Key offerings; Exhibits158: Sanofi SA - Overview; Exhibits159: Sanofi SA - Business segments; Exhibits160: Sanofi SA - Key news; Exhibits161: Sanofi SA - Key offerings; Exhibits162: Sanofi SA - Segment focus; Exhibits163: SIGA Technologies Inc. - Overview; Exhibits164: SIGA Technologies Inc. - Product / Service; Exhibits165: SIGA Technologies Inc. - Key offerings; Exhibits166: Soligenix Inc. - Overview; Exhibits167: Soligenix Inc. - Business segments; Exhibits168: Soligenix Inc. - Key offerings; Exhibits169: Soligenix Inc. - Segment focus; Exhibits170: Tonix Pharmaceuticals Holding Corp. - Overview; Exhibits171: Tonix Pharmaceuticals Holding Corp. - Product / Service; Exhibits172: Tonix Pharmaceuticals Holding Corp. - Key offerings; Exhibits173: Inclusions checklist; Exhibits174: Exclusions checklist; Exhibits175: Currency conversion rates for US$; Exhibits176: Research methodology; Exhibits177: Validation techniques employed for market sizing; Exhibits178: Information sources; Exhibits179: List of abbreviations